Relation between functional polymorphism of catalase gene (-262C>T) and recurrent depressive disorder

Activitas Nervosa Superior Rediviva

Volumn 51, Issue 3-4, 2009, Pages 150-155

  Galecki, Piotr ^a   Szemraj, Janusz ^a   Zboralski, Krzysztof ^a   Florkowski, Antoni ^a   Lewinski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Catalase; Recurrent depressive disorder; Single nucleotide polymorphism

Indexed keywords

EID: 79957862937     PISSN: 1337933X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Adibhalta RM, Dempsey R, Hatcher JF (2008). Integration of cytokine biology and lipid metabolism in stroke. Front Biosci. 13: 1250-1270.
2. Adibhatla R, Hatcher J (2006). Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 40: 376-387.
3. Al-Abrash AS, Al-Quobaili FA, Al-Akhras GN (2000). Catalase evaluation in different human diseases associated with oxidative stress. Saudi Med J. 21: 826-830.
4. Avshalumov MV, Rice ME (2002). NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices. J Neurophysiol. 87: 2896-2903.
5. Bachis A, Cruz MI, Nosheny RL, Mocchetti I (2008). Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neurosci Lett. 442: 104-108.
6. Bland JM, Altman DG (2000). Statistics notes. The odds ratio. BMJ. 320(7247): 1468.
7. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Bifaro L, et al (2008). Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms Neurosci Lett. 432: 237-242.
8. Cathcart MK (2004). Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol. 24: 23-28.
9. Chomczynski P (1993). A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 15: 532-534, 536-537.
10. Choi JY, Neuhouser ML, Barnett M, Hudson M, Kristal AR, Thornquist M, et al. (2007). Polymorphism in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev. 16: 1115-1120.
11. Christiansen L, Petersen HC, Bathum L, Frederiksen H, McGue M, Christensen K (2004). The catalase -262C/T promoter polymorphism and aging phenotypes. J Gerontol A Biol Sci Med Sci. 59: B886-889.
12. Coyle JT, Puttfarcken P (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262: 689-695.
13. Dringen R, Pawlowski PG, Hirrlinger J (2005). Peroxide detoxification by brain cells. J Neurosci Res. 79: 157-165.
14. El-Sohemy A, Cornelis MC, Park YW, Bae SC (2006). Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans. Rheumatol Int. 26: 388-392.
15. Eny KM, El-Sohemy A, Cornelis MC, Sung YK, Bae SC (2005). Catalase and PPARgamma2 genotype and risk of systemic lupus erythematosus in Koreans Lupus. 14: 351-355.
16. Fialkow L, Wang Y, Downey GP (2007). Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med. 42: 153-164.
17. Forsberg L, Lyrenäs L, de Faire U, Morgenstern R. (2001). A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med. 30: 500-505.
18. Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH (2006). Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophys Res Commun. 345: 1586-1591.
19. Georgotas A, McCue RE, Friedman E, Hapworth WE, Kim OM, Cooper TB, et al. (1986). Relationship of platelet MAO activity to characteristics of major depressive illness. Psychiatry Res. 19: 247-256.
20. Goulas A, Fidani L, Kotsis A, Mirtsou V, Petersen RC, Tangalos E, et al (2002). An association study of a functional catalase gene polymorphism, -262C-->T, and patients with Alzheimer's disease Neurosci Lett. 330: 210-213.
21. Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S (2004). Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes. 53: 2271-2280.
22. Halliwell B (2006). Oxidative stress and neurodegeneration: where are we now? J Neurochem. 97: 1634-1658.
23. Hashimoto K, Sawa A, Iyo M (2007). Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry. 62: 1310-1315.
24. Hattori F, Oikawa S (2007). Peroxiredoxins in the central nervous system. Subcell Biochem. 44: 357-374.
25. Hirono A, Sasaya-Hamada F, Kanno H, Fujii H, Yoshida T, Miwa S (1995). A novel human catalase mutation (358 T-->del) causing Japanese-type acatalasemia. Blood Cells Mol Dis. 21: 232-234.
26. Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y, et al. (2001). A polymorphism in the promoter region of catalase is associated with blood pressure levels Hum Genet. 109: 95-98.
27. Katon W, Lin EH, Kroenke K (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 29: 147-155.
28. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R (2003). Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 8: 365-370.
29. Kinnula VL, Everitt JI, Mangum JB, Chang LY, Crapo JD (1992). Antioxidant defense mechanisms in cultured pleural mesothelial cells. Am J Respir Cell Mol Biol. 7: 95-103.
30. Leonard BE (2001). The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 25: 767-780.
31. Leonard BE (2007). Inflammation, depression and dementia: are they connected?. Neurochem Res. 32: 1749-1756.
32. Levinson DF (2006). The genetics of depression: a review. Biol Psychiatry. 60: 84-92.
33. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A et al. (1998). Genome scan of schizophrenia Am J Psychiatry. 155: 741-750.
34. Li XM, Chlan-Fourney J, Juorio AV, Bennett VL, Shrikhande S, Bowen RC (2000). Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1). J Psychiatry Neurosci. 25: 43-47.
35. Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN (1983). CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry. 40: 405-406.
36. Lucca G, Comin CM, Valvassori SS, Réus GZ, Vuolo F, Petronilho F, et al (2009a). Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int. 54: 358-362.
37. Lucca G, Comin CM, Valvassori SS, Réus GZ, Vuolo F, Petronilho F, et al (2009b). Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatry Res. 43: 864-869.
38. Mak JC, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, et al (2007). Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J. 30: 684-690.
39. Mak JC, Leung HC, Ho SP, Ko FW, Cheung AH, Ip MS, et al. (2006). Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy. 36: 440-447.
40. Maes M (1995). Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 19: 11-38.
41. Maes M, Smith RS (1998). Fatty acid, cytokines, and major depression. Biol Psychiatry. 43: 313-314.
42. Nery FG, Borba EF, Hatch JP, Soares JC, Bonfá E, Neto FL (2007). Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry. 48: 14-19.
43. Pandey GN, Sharma RJ, Janicak PG, Davis JM (1992). Monoamine oxidase and cortisol response in depression and schizophrenia. Psychiatry Res. 44: 1-8.
44. Peet M, Murphy B, Shay J, Horrobin D (1998). Depletion of omega- fatty acids levels in red blood cells membranes of depressive patients. Biol Psychiatry. 43: 315-319.
45. Prasad K (2004). C-reactive protein increases oxygen radical generation by neutrophils. J Cardiovasc Pharmacol Ther. 9: 203-209.
46. Quan F, Korneluk RG, Tropak MB, Gravel RA (1986). Isolation and characterization of the human catalase gene Nucleic Acids Res. 14: 5321-5335.
47. Raison ChL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27: 24-31.
48. Saud K, Herrera-Molina R, Von Bernhardi R, (2005). Pro- and antiinflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox Res. 8: 277-287.
49. Szuster-Ciesielska A, Słotwińska M, Stachura A, Marmurowska-Michałowska H, Dubas-Slemp H, Bojarska-Junak A, et al. (2008). Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry. 32: 686-694.
50. Tate DJ Jr, Miceli MV, Newsome DA (1995). Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 36: 1271-1279.
51. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39: 44-84.
52. Warchoł T, Lianeri M, Wudarski M, Łacki JK, Jagodziński PP. (2008). Catalase -262C>T polymorphism in systemic lupus erythematosus in Poland Rheumatol Int. 28: 1035-1039.
53. Wen JK, Osumi T, Hashimoto T, Ogata M (1990). Molecular analysis of human acatalasemia. Identification of a splicing mutation J Mol Biol. 211: 383-393.
54. Wiemer EA, Ofman R, Middelkoop E, de Boer M, Wanders RJ, Tager JM. (1992). Production and characterisation of monoclonal antibodies against native and disassembled human catalase. J Immunol Methods. 151: 165-715.
55. Winterbourn Ch (2002). Biological reactivity and biomarkers of the neutrophil oxidation, hypochlorus acid. Toxicology. 181-182: 223-227.
56. World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.
57. Xu H, Chen Z, He J, Haimanot S, Li X, Dyck L, Li XM (2006). Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus. 16: 551-559.
58. Zhou XF, Cui J, DeStefano AL, Chazaro I, Farrer LA, Manolis AJ, et al. (2005). Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers. 21: 3-7